The effect of interleukin-2 on the blood-brain barrier in the 9L gliosarcoma rat model

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 • 600 citations

Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli

1984 • 600 citations

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

1986 • 534 citations

Transport of α-Aminoisobutyric Acid across Brain Capillary and Cellular Membranes

1983 • 510 citations

Statistics: A Biomedical Introduction

1980 • 466 citations

The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

1987 • 456 citations

The fate of interleukin-2 after in vivo administration.

1983 • 358 citations

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1984 • 299 citations

A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

1975 • 148 citations

Application of Quantitative Autoradiographic Measurements in Experimental Brain Tumor Models

1981 • 138 citations

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2.

1986 • 107 citations

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma

1986 • 89 citations

Immunobiology of primary intracranial tumors

1985 • 83 citations

Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary report

1977 • 79 citations

In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes

1986 • 76 citations

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion.

1987 • 75 citations

Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice.

1986 • 67 citations

Physicochemical Characterization of a Vascular Permeability Factor Produced by Con A-Stimulated Human Lymphocytes

1977 • 55 citations

The effect of hyperosmotic blood—brain barrier disruption on blood‐to‐tissue transport in ENU‐induced gliomas

1987 • 51 citations

Regional blood-to-tissue transport in RT-9 brain tumors

1983 • 44 citations

Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: A toxicity study

1978 • 38 citations

Preliminary clinical trial of immunotherapy for malignant glioma.

1987 • 26 citations